Classic Benjamin Graham Stock Screener
Free Value Investing for Intelligent Investors across Global Equity Markets, as recommended by Warren Buffett.
| Company Name | MIC | HQ | Fiscal Year | Last Updated | Curr Code | Previous Close | Graham Number | Graham Number(%) | NCAV/ NetNet | NCAV/ NetNet(%) | Graham Grade | Intrinsic Value | Intrinsic Value(%) | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 26811 | Marel hf (MAREL.AS) | XAMS | IS | 2023-12-31 | 3 days ago | EUR | 3.20 | 1.61 | 50.27% | 0.00 | 0.00% | Ungraded | 0.00 | 0.00% |
| 26812 | Morefield Group NV (MORE.AS) | XAMS | CW | 2022-12-31 | 3 days ago | EUR | 0.52 | 0.40 | 77.40% | 0.00 | 0.00% | Ungraded | 0.00 | 0.00% |
| 26813 | Relx PLC (REN.AS) | XAMS | GB | 2023-12-31 | 3 days ago | GBP | 0.00 | 5.95 | 0.00% | 0.00 | 0.00% | Ungraded | 0.00 | 0.00% |
| 26814 | Renewi PLC (RWI.AS) | XAMS | GB | 2023-03-31 | 3 days ago | EUR | 6.73 | 7.51 | 111.57% | 0.00 | 0.00% | Ungraded | 0.00 | 0.00% |
| 26815 | VEON Ltd (VEON.AS) | XAMS | NL | 2022-12-31 | 3 days ago | USD | 0.00 | 2.28 | 0.00% | 0.00 | 0.00% | Ungraded | 0.00 | 0.00% |
| 26816 | Vivoryon Therapeutics NV (VVY.AS) | XAMS | DE | 2022-12-31 | 3 days ago | EUR | 0.65 | 0.00 | 0.00% | 1.07 | 164.76% | Ungraded | 0.00 | 0.00% |
| 26817 | AIB Group PLC (A5G.IR) | XDUB | IE | 2022-12-31 | 3 days ago | EUR | 4.87 | 2.42 | 49.67% | 0.00 | 0.00% | Ungraded | 0.00 | 0.00% |
| 26818 | Amryt Pharma Holdings Ltd (AYP.IR) | 2019-12-31 | 3 years ago | GBP | 0.00 | 0.00 | 0.00% | 0.00 | 0.00% | Ungraded | 0.00 | 0.00% | ||
| 26819 | Applegreen PLC (APGN.IR) | 2019-12-31 | 3 years ago | EUR | 5.75 | 3.07 | 53.38% | 0.00 | 0.00% | Ungraded | 0.00 | 0.00% | ||
| 26820 | Aryzta AG (YZA.IR) | 2020-08-01 | 3 years ago | EUR | 0.71 | 0.00 | 0.00% | 0.00 | 0.00% | Ungraded | 0.00 | 0.00% |